Oral semaglutide
Sold by DoctorAdam · Oral tablet · every oral semaglutide record
Price
| Term | Published rate | Charged today |
|---|---|---|
| Advertised monthly starting program; invoice unverified Price conditions have not been established; the quoted figure is not a verified recurring rate. Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established. Advertised“From $129 | Get Treatment” | $129Published figure | Charged todayNot verified |
Price sources
- Advertised monthly starting program; invoice unverified · doctoradam.com — read October 2026
We earn nothing from this link. It opens DoctorAdam's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | 44 states: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming |
| Prescriber | Both |
| Cancellation | The product promises a full refund if no medication is prescribed. The refund policy prohibits cancellation/modification after processing or shipping and makes dispensed/shipped medications nonreturnable; confirmed delivered packages are not refundable. Generic membership terms allow cancellation/pausing of future membership charges but call paid fees nonrefundable. Their recurring membership/separate diagnostic language conflicts with the product no-membership/included-evaluation claim, so confirm which contract and fees apply before enrolling. https://doctoradam.com/pages/refund-policy https://doctoradam.com/pages/terms-and-conditions |
| Membership | Not disclosed |
| Consult fee | Not disclosed |
Recorded from doctoradam.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — Same FAQ page contains two contradictory state-coverage claims: one sentence says 'serving patients in 47 states and Washington, D.C., excluding NJ, MS, and AK,' while a separate, explicitly-enumerated 'We proudly serve the following states' list two lines later names only 44 states (also missing MA, RI, and VT). Recorded the explicit enumerated list per the register's rule to prefer a real list over a vague count, and flagged the contradiction here rather than reconciling it. No 'oral tirzepatide' category exists in this register's schema, so the Tirzepatide Oral Tablets product was recorded as compounded tirzepatide / oral-tablet. Cancellation was recorded as not found because the only relevant policy language found describes non-cancellable, non-refundable shipped orders, with no statement that an ongoing subscription itself can be canceled going forward.
- 2. October 2026 — The actual product advertises a starting $129 and describes consultation, prescription, medication and shipping in one monthly price. This does not establish the selected dose, exact first payment or renewal total. https://doctoradam.com/pages/oral-semaglutide
- 3. October 2026 — The product says no membership and includes evaluation, while the generic terms describe a recurring monthly membership, a separate diagnostic visit, separately paid Quest lab work and excess-service charges of $15 per consultation/lab interpretation or $125 per at-home draw. Applicability to this treatment is unresolved; none of these conditional fees is assumed universal or zero. https://doctoradam.com/pages/oral-semaglutide https://doctoradam.com/pages/terms-and-conditions
- 4. October 2026 — The FAQ identifies Olympia Pharmaceuticals and Carie Boyd Pharmaceuticals as network partners without assigning this specific formulation to either. It describes clinician review of submitted answers, with video or live chat in some states. Its explicit 44-state service list differs from its separate 47-states-plus-DC statement; the enumerated list is retained without inventing coverage for omitted states. https://doctoradam.com/pages/faq
12 further notes concern other DoctorAdam programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.